Star Pharmaceutical delists from Mainboard
The company is going private.
Star Pharmaceutical’s public float fell to 7.75%, less than the minimum Mainboard requirement of 10%, according to an SGX filing.
As of 5pm on Monday, the total number of shares and acceptances owned and controlled by the company and its concert parties reached 42.3 million or approximately 92.25% of shares.
As the pharmaceutical firm no longer holds the minimum free float requirement of the Mainboard, SGX shall close the trading of shares at the close of the offer.